June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Phosphatidylinositol 5-Kinase (PIKfyve) Negatively Regulates Photoreceptor Neuroprotection
Author Affiliations & Notes
  • Raju V S Rajala
    Ophthalmology and Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
    Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Mohd A Bhat
    Ophthalmology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Kenneth Teel
    Ophthalmology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Ammaji Rajala
    Ophthalmology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Footnotes
    Commercial Relationships   Raju Rajala None; Mohd Bhat None; Kenneth Teel None; Ammaji Rajala None
  • Footnotes
    Support  This work is supported by NIH EY00871, EY030024, and NEI Core grant EY12190, the BrightFocus Foundation, Inc., Oklahoma Center for Adult Stem Cell Research, and an unrestricted grant from Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3820. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Raju V S Rajala, Mohd A Bhat, Kenneth Teel, Ammaji Rajala; Phosphatidylinositol 5-Kinase (PIKfyve) Negatively Regulates Photoreceptor Neuroprotection. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3820.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) is a phosphoinositide 5-kinase that phosphorylates PI(3)P to generate PI(3,5)P2. PI(3)P is generated from PI by the action of class III PI3K, Vps34. Vps34 loss in rods resulted in rod degeneration. The 5’-phosphatase (called FIG4) dephosphorylates PI(3,5)P2 to PI(3)P. FIG4 loss also resulted in retinal degeneration. The role of PIKfyve in photoreceptor functions is unknown. This study examined the role of PIKfyve in the retina.

Methods : PIKfyve KO mice were generated under the control of retina-specific Chx10 (abbreviated as retPikfyve-/-) promoter. PI(3,5)P2 levels were measured and immunoblot analysis with anti-PIKfyve, anti-rhodopsin, cone-arrestin, and sodium-potassium ATPase-alpha (NKAα) antibodies was performed in PIKfyve floxed and retPikfyve-/- mouse retinas. Structure and function were assessed at 8 months of age. PIKfyve floxed and retPikfyve-/- mice were subjected to light stress (LS) at 10,000 lux for 7 days. PI(3,5)P2 is needed for late endosome and lysosome maturation. We examined the expression of NKAα, removed through the lysosomal degradation pathway. One week after LS, mice were subjected to ERG, followed by histological examination.

Results : retPikfyve-/- retina had 70% less PIKfyve protein and more than 80% less PI(3,5)P2 when compared to PIKfyve floxed retina. However, there was no significant difference in retinal function and structure between PIKfyve floxed and retPikfyve-/- mice at 8 months of age. Light-stressed PIKfyve floxed mice exhibited photoreceptor degeneration; the structure was well preserved in light-stressed retPikfyve-/- mice. Immunoblots showed no significant difference in the levels of rhodopsin, NKAα, and cone arrestin between PIKfyve floxed and retPikfyve-/- mice without LS. Light-stressed PIKfyve floxed mice had significantly reduced levels of rhodopsin, cone arrestin, and NKAα compared with light-stressed retPikfyve-/- mice. Light-stressed retPikfyve-/- mice had a normal retinal function and well-preserved retinal structure, whereas light-stressed PIKfyve floxed mice had significantly reduced function and exhibited retinal degeneration.

Conclusions : The data suggest that PIKfyve-generated PI(3,5)P2 regulates late endosome and lysosome maturation, and loss of PIKfyve promotes photoreceptor neuroprotection. Modulating the PIKfyve activity under retinal degenerative conditions may have therapeutic benefits.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×